D-0340-2018 Class I Terminated

Recalled by AuroMedics Pharma LLC — East Windsor, NJ

FDA drug recall D-0340-2018 was initiated by AuroMedics Pharma LLC on Dec 4, 2017 and is designated Class I. Reason for recall: Presence of Particulate Matter: One vial from a lot of Pantoprazole Sodium for Injection (40 mg) contained a piece of glass The recall status is terminated (terminated Mar 17, 2020). Affected quantity: 66,100 vials.

Recall details

Product Type
Drugs
Report Date
Feb 14, 2018
Initiation Date
Dec 4, 2017
Termination Date
Mar 17, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
66,100 vials

Product description

Pantoprazole Sodium for Injection, 40 mg per vial, single dose vial, Rx only, Manufactured in India for: AuroMedics Pharma LLC, 6 Wheeling ROad, Dayton, NJ 08810. NDC 55150-202-00

Reason for recall

Presence of Particulate Matter: One vial from a lot of Pantoprazole Sodium for Injection (40 mg) contained a piece of glass

Distribution pattern

Product was distributed nationwide in the USA

Code information

Lot # CPO170035

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0340-2018
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0340-2018. Report a data issue: hello@regdatalab.com.